AKUMS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Akums Drugs and Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 688.5 INR -1.92% Market Closed

Market Cap: ₹105.4B

A	Akums Drugs and Pharmaceuticals Ltd NSE:AKUMS	IN
M	Myriad Genetics Inc F:MYD	US
	Aegon NV OTC:AEGOF	NL
M	MPH Health Care AG XMUN:93M1	DE
C	Compass Group PLC OTC:CMPGY	UK
J	JOYY Inc XHAM:0YYA	SG
E	Electronic Arts Inc F:ERT	US
T	Taiheiyo Cement Corp SWB:TIE	JP
B	Bank of Communications Co Ltd SWB:C4C	CN
	Palo Alto Networks Inc NASDAQ:PANW	US
	Deutsche Boerse AG XETRA:DB1	DE
	Telefonaktiebolaget LM Ericsson STO:ERIC B	SE
F	First Majestic Silver Corp XBER:FMV	CA
S	Sino Land Co Ltd OTC:SNLAF	HK

Profitability Summary

Akums Drugs and Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

41%

Sustainable 3Y Average Gross Margin

41%

Low Operating Margin

Low 3Y Average Operating Margin

Low Net Margin

Low 3Y Average Net Margin

Exceptional Free Cash Flow Margin

31%

Strong 3Y Average Free Cash Flow Margin

21%

Positive ROE

11%

Positive 3Y Average ROE

13%

Positive ROIC

10%

Positive 3Y Average ROIC

10%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.